Product spotlight

6
Dec

Genoskin launches spatial skin biology platform MANTIS®

PRESS RELEASE - Toulouse, France & Salem, MA, USA - December 6, 2021 GENOSKIN LAUNCHES SPATIAL SKIN BIOLOGY PLATFORM MANTIS® Genoskin launches MANTIS®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS® (Multiplex ANnotated Tissue Imaging System) platform was developed at Infinity (Inserm U1291, France) by a team of experts under the guidance of Dr. Nicolas Gaudenzio, who
Read more
28
Oct

De-risking antiaging trials with ex vivo skin models

Article written by Danny Sullivan and first published in Longevity Technology on October 28th, 2021. The original article is available here. Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing With its proprietary ex vivo human skin technologies, French partner research organisation Genoskin says it is paving the way to “better,
Read more
15
Jun

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals Interested in trying NativeSkin access®? Do you still think that sourcing skin samples directly from hospitals is the only valid way? Let us change your mind with these top advantages to ordering  NativeSkin access® online! NativeSkin access® is a patented human skin model that makes the culture, treatment,
Read more
10
Jun

Injection site reactions platform

ISR PlatformA PROPRIETARY PLATFORM TO TEST INJECTION SITE REACTIONS IN HUMANS AHEAD OF CLINICAL TRIAL.A NEW PROPRIETARY RESEARCH TOOL TO IDENTIFY MAST CELLS-DEPENDENT & INDEPENDENT INJECTION SITE REACTIONS IN HUMAN SKIN. Today, biologics represent one of the fastest growing markets within the pharmaceutical industry. The pipeline of biological drugs is growing at a rapid pace with a global market expected
Read more
30
Nov

Human connective tissue mast cells

Human connective tissue mast cells A cellular model to better understand the underlying mechanisms of Injection Site Reactions (ISRs) and other severe allergic reactions. Mast cell culture assays are critical to better understand the kinetics and dynamics underlying inflammatory reactions. Genoskin’s team of experts has developed a method to grow connective tissue-type mast cells (CTMCs) derived from the peripheral blood
Read more
28
Oct

A unique ex vivo perfused human skin model to test pharmacokinetic and systemic administration in human skin

The FlowSkin® platform : a unique ex vivo perfused human skin model to test pharmacokinetic and systemic administration in human skin When human tissue culture meets microfluidic technology, it leads to the first perfused human skin model ; an amazing platform to overcome the challenges of drug development and replace animal testing. Almost 10 years ago now, Genoskin developed the
Read more